Financhill
Back

Sarepta Therapeutics Vs. SoftBank Group Industry Stock Comparison

Sell
26

SRPT
Sarepta Therapeutics

Last Price:
120.15
Seasonality Move:
-0.82%
Sell
45

SFTBY
SoftBank Group

Last Price:
29.86
Seasonality Move:
0.57%
Sell
26
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $120.40. The Score for SRPT is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
SoftBank Group (SFTBY) is a Sell

Is SoftBank Group a Buy, Sell or Hold?

  • The current SoftBank Group [SFTBY] share price is $29.86. The Score for SFTBY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • SFTBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $120.40
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.

SFTBY Stock Price Chart

What is SoftBank Group's stock price today?

  • The SoftBank Group share price today is $29.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SFTBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.41 Sell
Relative Strength Index (14 RSI): 32.45 Sell
Chaikin Money Flow: 79309 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (122.31 - 130.81) Sell
Bollinger Bands (100): (122.97 - 147.31) Sell

SFTBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.27 Buy
Relative Strength Index (14 RSI): 53.06 Buy
Chaikin Money Flow: 400281 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.84 - 30.42) Buy
Bollinger Bands (100): (27.1 - 32.74) Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 122.86 Sell
20-day SMA: 124.78 Sell
50-day SMA: 132.71 Sell
200-day SMA: 128.28 Sell
8-day EMA: 122.39 Sell
20-day EMA: 125.48 Sell
50-day EMA: 130.61 Sell
200-day EMA: 128.3 Sell

SFTBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.89 Sell
20-day SMA: 29.58 Buy
50-day SMA: 28.51 Buy
200-day SMA: 27.85 Buy
8-day EMA: 29.75 Buy
20-day EMA: 29.52 Buy
50-day EMA: 29.38 Buy
200-day EMA: 27.81 Buy

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.81 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

SoftBank Group Earnings Growth & SFTBY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

SoftBank Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):